Ionsys

Nchi: Umoja wa Ulaya

Lugha: Kiingereza

Chanzo: EMA (European Medicines Agency)

Nunua Sasa

Taarifa za kipeperushi Taarifa za kipeperushi (PIL)
06-11-2018
Tabia za bidhaa Tabia za bidhaa (SPC)
06-11-2018

Viambatanisho vya kazi:

fentanyl hydrochloride

Inapatikana kutoka:

Incline Therapeutics Europe Ltd

ATC kanuni:

N02AB03

INN (Jina la Kimataifa):

fentanyl

Kundi la matibabu:

Analgesics

Eneo la matibabu:

Pain, Postoperative

Matibabu dalili:

Ionsys is indicated for the management of acute moderate to severe post-operative pain in adult patients.

Bidhaa muhtasari:

Revision: 2

Idhini hali ya:

Withdrawn

Idhini ya tarehe:

2015-11-18

Taarifa za kipeperushi

                                28
B. PACKAGE LEAFLET
Medicinal product no longer authorised
29
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
IONSYS 40 MICROGRAMS PER DOSE TRANSDERMAL SYSTEM
FENTANYL
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, please ask your doctor or your
nurse.
•
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if
their symptoms are the same as yours.
•
If you get any side effects, talk to your doctor or nurse. This
includes any possible side effects not
listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What IONSYS is and what it is used for
2.
Before you use IONSYS
3.
How to use IONSYS
4.
Possible side effects
5.
How to store IONSYS
6.
Contents of the pack and other information
1.
WHAT IONSYS IS AND WHAT IT IS USED FOR
What IONSYS is
IONSYS is a transdermal system (to be applied on intact skin) that
contains a strong analgesic (pain
reliever) medicine called fentanyl.
What IONSYS is used for
IONSYS is used to treat short-term moderate to severe pain in adults
after an operation. IONSYS is
used in hospital only.
How IONSYS works
IONSYS is a small device applied to the skin of your upper arm or
chest. It works by delivering
fentanyl through your skin to relieve your pain.
You must talk to a doctor if you do not feel better or if you feel
worse.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE IONSYS
DO NOT USE IONSYS:
•
if you are allergic
(hypersensitive)
_ _
to fentanyl, or any of the other ingredients of IONSYS (listed
in section 6).
•
if you suffer from severe breathing problems or cystic fibrosis.
WARNINGS AND PRECAUTIONS
Talk to your doctor or nurse before using IONSYS if:
•
you have a severe or persistent lung disease, or any breathing
problems
•
you have a very slow heart rate, low blood pressure, or other serious
heart problem
•
you have problems with your liver or kidneys
•
you ha
                                
                                Soma hati kamili
                                
                            

Tabia za bidhaa

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
Medicinal product no longer authorised
2
1.
NAME OF THE MEDICINAL PRODUCT
IONSYS 40 micrograms per dose transdermal system
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each IONSYS system contains fentanyl hydrochloride equivalent to 9.7
mg of fentanyl and delivers
40 micrograms fentanyl per dose, to a maximum of 80 doses (3.2 mg/24
hours).
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Transdermal system
IONSYS is composed of an electronic controller and a drug unit with
two hydrogels. The controller is
white with the identifier ‘IONSYS
®’
and has
a digital display, a light window, and a recessed dose
activation button. The drug unit is blue on the side that connects to
the controller and has a red bottom
housing containing the hydrogels, one of which contains the fentanyl.
The assembled IONSYS
product measures 47 mm x 75 mm.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
IONSYS is indicated for the management of acute moderate to severe
post-operative pain in adult
patients.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_ _
IONSYS is restricted to hospital use only. Treatment should be
initiated by and remain under the
guidance of a physician experienced in the management of opioid
therapy. Due to the well-known
potential of abuse of fentanyl, physicians should evaluate patients
for a history of drug abuse (see
section 4.4).
Posology
Patients should be titrated to an acceptable level of analgesia prior
to initiating use of IONSYS (see
section 5.1).
IONSYS should only be activated by the patient.
Each dose of IONSYS delivers 40 micrograms of fentanyl over a 10
minute period, to a maximum of
240 micrograms per hour (6 doses each of 10 minutes duration). IONSYS
will operate for 24 hours
after the system is assembled or for 80 doses, whichever comes first,
and then becomes inoperative.
After 24 hours or 80 doses, a new system should be applied if
necessary. Each new system should be
placed on a new skin site. With each new IONSYS application
                                
                                Soma hati kamili
                                
                            

Nyaraka katika lugha zingine

Taarifa za kipeperushi Taarifa za kipeperushi Kibulgaria 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kibulgaria 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kibulgaria 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kihispania 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kihispania 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kihispania 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kicheki 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kicheki 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kicheki 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kidenmaki 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kidenmaki 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kidenmaki 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kijerumani 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kijerumani 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kijerumani 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kiestonia 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kiestonia 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiestonia 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kigiriki 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kigiriki 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kigiriki 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kifaransa 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kifaransa 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kifaransa 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kiitaliano 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kiitaliano 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiitaliano 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kilatvia 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kilatvia 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kilatvia 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kilithuania 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kilithuania 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kilithuania 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kihungari 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kihungari 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kihungari 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kimalta 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kimalta 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kimalta 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kiholanzi 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kiholanzi 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiholanzi 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kipolandi 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kipolandi 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kipolandi 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kireno 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kireno 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kireno 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kiromania 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kiromania 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiromania 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kislovakia 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kislovakia 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kislovakia 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kislovenia 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kislovenia 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kislovenia 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kifinlandi 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kifinlandi 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kifinlandi 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kiswidi 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kiswidi 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiswidi 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kinorwe 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kinorwe 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kiaisilandi 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kiaisilandi 06-11-2018
Taarifa za kipeperushi Taarifa za kipeperushi Kroeshia 06-11-2018
Tabia za bidhaa Tabia za bidhaa Kroeshia 06-11-2018
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kroeshia 06-11-2018

Tafuta arifu zinazohusiana na bidhaa hii

Tazama historia ya hati